LivaNova Reports Second Quarter 2019 Results

Go back to LivaNova Reports Second Quarter 2019 Results

Livanova (LIVN) PT Raised to $91 at Needham & Company

July 31, 2019 1:33 PM EDT

Needham & Company analyst Mike Matson raised the price target on Livanova (NASDAQ: LIVN) to $91.00 (from $87.00) while maintaining a Buy rating.

The analyst commented, "LIVN's 2Q19 revenue and EPS beat consensus and management reiterated its 2019 guidance. Organic revenue growth slowed to (1%) in 2Q19... More

LivaNova plc (LIVN) Tops Q2 EPS by 5c

July 31, 2019 6:16 AM EDT

LivaNova plc (NASDAQ: LIVN) reported Q2 EPS of $0.70, $0.05 better than the analyst estimate of $0.65. Revenue for the quarter came in at $272.2 million versus the consensus estimate of $275.08 million.

"Sales results for second quarter 2019 were strong in Cardiovascular, driven by double-digit growth in Advanced... More